Русский
English
+7 (495) 676-43-60
109044, Moscow, Lavrov lane., 6
Helpline for the pharmaceutical industry
pharmprom@gilsinp.ru
Drugs track and trace helpline
MARKIROVKA@GILSINP.RU
About
Message from Director
About Institute
History
Leadership
Payment details
Useful links
Frequently asked questions
Activities
Inspectorate
Good engineering practice
Monitoring of industry markets and government programs
R&D
Medical center
Events
Schedule of expert and advisory seminars
Shedule of events
GMP-conference
Documents
Departmental orders, regulatory legal acts
Inspection
R&D
Medical activity
Good engineering practices
Quality management system
Data Integrity and validation of computerized systems
Materials of the III GMP conference
Materials of ISPE Affiliate Opening presentation
Press center
News
Publications
Logotypes
Principles of interaction with media
Contacts
Fighting Corruption
Front page
»
Events
»
The preparation of related quality products. Claims and product recalls
The preparation of related quality products. Claims and product recalls
Lecturer:
Y. Podpruzhnikov
Date:
22 Oct. – 07 Dec. 2016
Latest news
The Cooperation Agreement was signed between State Institute of Drugs and Good Practices and National agency of pharmaceutical products of Algeria
On January 14, the Cooperation Agreement was signed between FSI “State Institute of Drugs and...
1/14/2021
SID&GP passed the recertification audit of the Quality Management System according to ISO 9001:2015
In December 2020, SID&GP passed a recertification audit of the Quality Management System for compliance...
12/23/2020
Russian Federation has submitted an application for the Pharmaceutical Inspection Co-operation Scheme PIC/S accession
On December 18, Russian Federation submitted an application for the Pharmaceutical Inspection Co-operation Scheme PIC/S...
12/22/2020
All news
Schedule of events
2021 © News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution content is expressly prohibited without the prior written consent of external communications FSI «SID and GP».
